unknown
Stage
About
Cayuga Biotech develops therapeutics that harness the body’s innate hemostatic mechanisms to treat life‑threatening hemorrhage and bleeding disorders. Its programs target noncompressible hemorrhage and coagulation dysfunctions such as those caused by platelet inhibitors.
Explore Cayuga Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.